Oct 20
OSSUY · Embla Medical HF
Market Cap
$1.80B
Shares
425.05M
Volume · Oct 20
1000
Avg daily vol (2 sessions)
652
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.23
Open$4.23
Day$4.23–4.23
52W close$3.67–5.61
Avg vol 30d506
Short int237 · 0.0% of shares
Short vol100%
Last earningsOct 20, 2026
DataFeb 2020–Oct 2026
Up next
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 25.6 · fear
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−7%
below
RSI (14)
47
neutral
MACD trend
Negative
52-week position
29%
mid-range
Momentum
relative strength
1-month return
+3%
trailing
YTD return
−21%
this year
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of shares out · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
1061%
annualized · 1-yr
Max drawdown
−84%
past year
ATR
11.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−7%
Bearish
RSI (14)
47
Neutral
MACD trend
Negative
Bearish
52-week position
29%
Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of shares out · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $4
Now $4 · 29%
Range high $6
vs 50-day avg -7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OSSUY
this stock
Embla Medical HF
|
$1.80B | -21.4% | — | — | 0.0% |
|
ABT
Abbott Laboratories
|
$190.39B | -12.3% | +5.7% | 41.0 | 1.0% |
|
MDT
Medtronic plc
|
$130.22B | +6.0% | +8.4% | 25.1 | 10.9% |
|
SYK
Stryker Corp
|
$124.06B | -7.3% | +11.2% | 34.7 | 1.5% |
|
BSX
Boston Scientific Corp
|
$61.96B | -55.2% | +12.5% | 18.1 | 2.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OSSUY | -5.2% | +2.9% | — | +1.9% | -21.5% |
| SPY | -1.2% | -0.6% | +8.1% | +0.8% | +12.8% |
| vs SPY | -4.0% | +3.5% | — | +1.1% | -34.2% |
Capital returns
Latest dividend
$0.0219
/ share · ex Mar 20, 2020
Paid (TTM)
$0.00
/ share · 0 payouts
Dividend yield (TTM, derived)
— · no payout in the trailing year
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.